Current optimal pharmacologic therapies for overactive bladder
YH Jiang, HC Kuo - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
Introduction Overactive bladder (OAB) is a common syndrome in adults. Current
pharmacologic treatment includes antimuscarinic agents and β-3 adrenoceptor agonists. For …
pharmacologic treatment includes antimuscarinic agents and β-3 adrenoceptor agonists. For …
[PDF][PDF] Comparison of the efficacy and safety of onabotulinum toxin A and mirabegron for overactive bladder in elderly patients.
A Karakeci, A Keles, R Onur - European Review for Medical & …, 2024 - researchgate.net
OBJECTIVE: This study aimed to investigate the efficacy and tolerability of mirabegron and
onabotulinum toxin A (BoNT/A) injections for overactive bladders. The treatment we …
onabotulinum toxin A (BoNT/A) injections for overactive bladders. The treatment we …